Nymox Pharmaceutical Corporation (NYMXF)
USD 0.1
(23.3%)
USD 0.1
(23.3%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 750 Thousand USD | 333.53% |
| 2022 | 173 Thousand USD | -55.75% |
| 2021 | 391 Thousand USD | -8.22% |
| 2020 | 426 Thousand USD | 189.8% |
| 2019 | 147 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 931 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | - USD | -100.0% |
| 2023 Q4 | 750 Thousand USD | 6718.18% |
| 2023 Q3 | 11 Thousand USD | -98.63% |
| 2023 Q2 | 805 Thousand USD | 606.14% |
| 2023 Q1 | 114 Thousand USD | -34.1% |
| 2022 Q1 | 339 Thousand USD | -13.3% |
| 2022 Q4 | 173 Thousand USD | -23.79% |
| 2022 Q3 | 227 Thousand USD | -20.07% |
| 2022 Q2 | 284 Thousand USD | -16.22% |
| 2021 Q4 | 391 Thousand USD | -12.13% |
| 2021 Q3 | 445 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 98.18% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 81.805% |
| SQZ Biotechnologies Company | 27.47 Million USD | 97.27% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 98.271% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 97.48% |
| Mesoblast Limited | 118.7 Million USD | 99.368% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | 20.909% |
| Genus plc | 233.1 Million USD | 99.678% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 74.406% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 44.179% |
| Marizyme, Inc. | 18.71 Million USD | 95.993% |
| ContraFect Corporation | 2.88 Million USD | 73.967% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -453.559% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | 48.144% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | 67.755% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 86.745% |
| MultiCell Technologies, Inc. | 202.58 USD | -370124.109% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 98.695% |
| EV Biologics, Inc. | 1.49 Million USD | 49.824% |
| Q BioMed Inc. | 4.1 Million USD | 81.752% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 97.734% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -19.033% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | 38.943% |
| Biomind Labs Inc. | 735.54 Thousand USD | -1.966% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 99.563% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 94.229% |
| Skye Bioscience, Inc. | 4.61 Million USD | 83.75% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | 15.547% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -429.968% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 87.226% |
| IMV Inc. | 28.88 Million USD | 97.403% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -2816.132% |
| Curative Biotechnology, Inc. | 2.25 Million USD | 66.79% |
| GB Sciences, Inc. | 1.75 Million USD | 57.37% |
| Alpha Cognition Inc. | 1.22 Million USD | 38.543% |
| HST Global, Inc. | 98.31 Thousand USD | -662.823% |
| CSL Limited | 12.18 Billion USD | 99.994% |
| Halberd Corporation | 150 Thousand USD | -400.0% |
| Enzolytics Inc. | 996.33 Thousand USD | 24.724% |
| Resverlogix Corp. | 6.49 Million USD | 88.446% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -57.068% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -193.436% |
| argenx SE | 20 Million USD | 96.25% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 98.354% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 72.311% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -7234.963% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.82% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -273.849% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | 68.72% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -227.095% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 98.891% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 75.216% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -108.501% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 96.311% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -404.527% |
| BioStem Technologies, Inc. | 4.71 Million USD | 84.081% |
| ONE Bio Corp. | 19.71 Million USD | 96.196% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -199.782% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -201.544% |
| Agentix Corp. | 50 Thousand USD | -1400.0% |
| LadRx Corporation | 33.6 Thousand USD | -2131.744% |
| Cell Source, Inc. | 9.25 Million USD | 91.896% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | 0.82% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | 0.82% |
| NovAccess Global Inc. | 2.19 Million USD | 65.907% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 89.396% |
| Itoco Inc. | 228.37 Thousand USD | -228.404% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -255.492% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 84.949% |
| Kadimastem Ltd | 891.22 Thousand USD | 15.846% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -86.637% |
| CytoDyn Inc. | 30.07 Million USD | 97.506% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -54.868% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -113.161% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 90.409% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -512.245% |
| Rebus Holdings, Inc. | 310 Thousand USD | -141.935% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 84.161% |
| International Stem Cell Corporation | 4.17 Million USD | 82.049% |
| Bioxytran, Inc. | 1.92 Million USD | 61.039% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1101.673% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 65.611% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 90.981% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 91.264% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | 51.783% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -179.851% |
| Neutra Corp. | 54.15 Thousand USD | -1284.888% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | 59.016% |
| PureTech Health plc | 25.51 Million USD | 97.06% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | 38.737% |
| IXICO plc | 472.02 Thousand USD | -58.891% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 95.162% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 98.795% |
| CSL Limited | 12.18 Billion USD | 99.994% |
| Cellectis S.A. | 92.77 Million USD | 99.192% |